Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma

Oncology Reports

Volumn 25, Issue 2, 2011, Pages 359-366

  Chen, Hong Lei ^a   Fan, Li Fang ^a   Gao, Jun ^a   Ouyang, Jing Ping ^a   Zhang, Yu Xia ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Caveolin 1; Lung carcinoma; Mutation; Quantum dots

Indexed keywords

CAVEOLIN 1;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELLULAR DISTRIBUTION; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CAVEOLIN 1; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TISSUE ARRAY ANALYSIS;

EID: 78651351550     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1095     Document Type: Article

References (25)

1. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250, 2005.
2. Galbiati F, Volonte D, Brown AM, et al: Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J Biol Chem 275: 23368-23377, 2000. (Pubitemid 30646240)
3. Cerezo A, Guadamillas MC, Goetz JG, et al: The absence of caveolin-1 increases proliferation and anchorage-independent growth by a Rac-dependent, Erk-independent mechanism. Mol Cell Biol 29: 5046-5059, 2009.
4. Bartholomew JN, Volonte D and Galbiati F: Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway. Cancer Res 69: 2878-2886, 2009.
5. Wiechen K, Diatchenko L, Agoulnik A, et al: Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159: 1635-1643, 2001.
6. Bender FC, Reymond MA, Bron C and Quest AF: Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60: 5870-5878, 2000.
7. Zhang H, Su L, Müller S, et al: Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer 99: 1684-1694, 2008.
8. Hurlstone AF, Reid G, Reeves JR, et al: Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene 18: 1881-1890, 1999.
9. Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, Karakiewicz PI and Shariat SF: Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate 67: 614-622, 2007. (Pubitemid 46685281)
10. Yoo SH, Park YS, Kim HR, et al: Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. Lung Cancer 42: 195-202, 2003. (Pubitemid 37268030)
11. Zhang ZB, Cai L, Zheng SG, Xiong Y and Dong JH: Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery. Pathol Oncol Res 15: 495-502, 2009.
12. Tholouli E, Sweeney E, Barrow E, Clay V, Hoyland JA and Byers RJ: Quantum dots light up pathology. J Pathol 216: 275-285, 2008.
13. Chen H, Xue J, Zhang Y, Gao J and Yu B: Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Histol 40: 261-268, 2009.
14. Sauter G, Simon R and Hillan K: Tissue microarrays in drug discovery. Nat Rev Drug Discov 2: 962-972, 2003.
15. Kato T, Miyamoto M, Kato K, et al: Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma. Cancer Lett 214: 121-128, 2004.
16. Hayashi K, Matsuda S, Machida K, et al: Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res 61: 2361-2364, 2001. (Pubitemid 32685805)
17. Gao XY, Cui RM, Levenson L, Chung WK and Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22: 969-976, 2004.
18. Yu X, Chen L, Deng Y, et al: Fluorescence analysis with quantum dot probes for hepatoma under one- and two-photon excitation. J Fluoresc 17: 243-247, 2007. (Pubitemid 46355032)
19. Wikman H, Seppänen JK, Sarhadi VK, et al: caveolin-1 as tumor markers in lung cancer detected by combined use of cDNA and tissue microarrays. J Pathol 203: 584-593, 2004. (Pubitemid 38529039)
20. Cassoni P, Daniele L, Maldi E, et al: Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases. Histopathology 55: 20-27, 2009.
21. Ho CC, Kuo SH, Huang PH, Huang HY, Yang CH and Yang PC: Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. Lung Cancer 59: 105-110, 2008.
22. Ho CC, Huang PH, Huang HY, Chen YH, Yang PC and Hsu SM: Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol 161: 1647-1656, 2002.
23. Xue J, Chen H, Diao L, Chen X and Xia D: Expression of caveolin-1 in tongue squamous cell carcinoma by quantum dots. Eur J Hist 54: 99-103, 2010.
24. Ando T, Ishiguro H, Kimura M, et al: The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep 18: 601-609, 2007.
25. Li T, Sotgia F, Vuolo MA, et al: Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 168: 1998-2013, 2006.